TL;DR
Researchers have engineered Escherichia coli to produce styrene, a key petrochemical building block, with significantly improved yields. By combining strain engineering with an in situ product recovery (ISPR) strategy using an organic solvent, they achieved the highest reported styrene titer in bacterial hosts to date, paving the way for more sustainable and economical bio-based styrene production.
What Problem Does This Paper Address?
Styrene is a high-volume commodity chemical, crucial for the production of numerous polymers like polystyrene and ABS plastics. Currently, its production relies heavily on the petrochemical industry, which involves energy-intensive processes like catalytic dehydrogenation of ethylbenzene. This reliance on fossil fuels and the significant energy input make styrene production environmentally costly. While biological production of styrene has been explored, previous attempts in microbial hosts have suffered from low productivities, making them economically unviable for commercial scale. Furthermore, styrene itself can be toxic to microbial cells, limiting growth and production titers. This paper addresses the challenge of achieving economically competitive, bio-based styrene production by enhancing both the microbial production capacity and the recovery efficiency.
Methods
The researchers employed a multi-pronged approach:
- Strain Engineering: They started with a previously engineered E. coli strain (YHP05) known for high L-phenylalanine production. To create a de novo styrene biosynthesis pathway, they introduced two key enzymes: phenylalanine-ammonia lyase (PAL) from Arabidopsis thaliana and ferulic acid decarboxylase (FDC) from Saccharomyces cerevisiae. This pathway converts L-phenylalanine into styrene in a single step. They also optimized the expression of these genes by using different plasmid constructs and promoters to ensure sufficient precursor (L-phenylalanine) and enzyme availability.
- In Situ Product Recovery (ISPR): To mitigate styrene's toxicity and facilitate its removal from the culture broth, they implemented an ISPR strategy. This involved adding an organic solvent, n-dodecane, directly to the culture medium. N-dodecane selectively extracts styrene as it is produced, preventing its accumulation to toxic levels and simplifying downstream recovery.
- Media Optimization: They explored different culture media, moving from complex Luria-Bertani (LB) broth to a defined minimal medium (PHE) to reduce costs. Further optimization involved supplementing the minimal medium with various complex sources like yeast extract, peptone, tryptone, and casamino acids to enhance cell growth and styrene production. Yeast extract proved to be the most effective supplement.
- Fed-Batch Cultivation with Gas Stripping: To scale up production and further minimize styrene loss, they conducted fed-batch cultivations in a 5 L bioreactor. Crucially, they incorporated a gas-stripping system by connecting three consecutive bottles containing n-dodecane to the bioreactor's air outlet. This setup captured volatile styrene that might otherwise be lost through aeration, allowing for a more accurate assessment of total styrene production.
Datasets
Not discussed in the paper. The study focuses on experimental results from engineered microbial strains and laboratory-scale bioreactor cultivations.
Key Insights and Ideas
- Synergistic Effect of ISPR and Strain Engineering: The combination of an engineered E. coli strain capable of efficient styrene synthesis and ISPR using n-dodecane was critical. ISPR not only reduced toxicity but also likely shifted the metabolic flux towards styrene production by continuously removing the product.
- Importance of Enzyme Expression Balance: The study highlighted how the expression levels of the two key enzymes (PAL and FDC) could be affected by plasmid design (e.g., bicistronic expression). Optimizing gene expression through different plasmid constructs was essential for maximizing styrene yield.
- Minimal Media Advantage: Transitioning from complex to defined minimal media, with strategic supplementation (yeast extract), proved beneficial for both cost-effectiveness and achieving higher styrene titers, suggesting that precise nutrient control can enhance production.
- Volatile Product Management is Key: The significant increase in styrene titer achieved by implementing the gas-stripping ISPR system in fed-batch cultivation underscores the challenge of volatile product recovery. Capturing off-gas losses is vital for accurate yield determination and maximizing overall recovery.
- Potential for Broader Applications: The engineered E. coli strain, initially developed for L-phenylalanine overproduction, shows promise for producing other L-phenylalanine-derived aromatic compounds, expanding its utility beyond styrene.
Key Results
- Flask Cultivation: In optimized flask cultures using the engineered E. coli YHP05 with ISPR, a styrene titer of 1.7 ± 0.1 g/L was achieved. This was a significant improvement over previous reports.
- Fed-Batch Cultivation (Initial): An initial fed-batch cultivation in a 5 L bioreactor yielded 2.0 g/L of styrene.
- Fed-Batch Cultivation (with Gas Stripping): By implementing the three-bottle gas-stripping ISPR system, the total styrene titer reached an impressive 5.3 ± 0.2 g/L at 60 hours, with a productivity of 88.3 mg/L/h. This represents the highest reported titer for de novo styrene production in bacterial hosts to date.
- Toxicity Mitigation: The ISPR strategy allowed cells to grow to higher densities and produce styrene at titers significantly above the previously known inhibitory concentration of 0.2 g/L.
Limitations and Future Work
- Solvent Recovery Improvement: While the gas-stripping ISPR system was effective, the study notes that styrene was still being lost in the last bottle, indicating that the solvent recovery process could be further improved. Future work could involve more efficient stripping systems, cooling jacket condensers, and optimized airflow rates.
- Economic Viability: While the titers are promising, further techno-economic evaluations would be necessary to confirm the commercial viability of this bio-based styrene production process compared to petrochemical routes.
- Broader Application Exploration: The authors suggest that the engineered strain could be a platform for producing other L-phenylalanine-derived aromatic compounds, which warrants further investigation.
Summary updated